Linda Novak

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

Yunhui Wu, Alice E. Loper, Elizabeth Landis et al. · International Journal of Pharmaceutics · 2004 · 271 citations

Nanomedicine, Pharmaceutical Science, Engineering +9

Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.

David C. Underwood, Ruth R. Osborn, Linda Novak et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 127 citations

Regiospecific Intestinal Absorption of the HIV Protease Inhibitor L-735,524 in Beagle Dogs

Gloria Y. Kwei, Linda Novak, Lisa Hettrick et al. · Pharmaceutical Research · 1995 · 26 citations

Supply Chain Management: A Recommended Performance Measurement Scorecard

Larry S. Klapper, Neil Hamblin, Linda Hutchison et al. · 1999 · 24 citations

Logistics Processes, Enterprise Metrics, Supply Chain Performance +11

Lymphatic uptake of MK-386, a sterol 5α-reductase inhibitor, from aqueous and lipid formulations

Gloria Y. Kwei, Linda Novak, Lisa H Hettrick et al. · International Journal of Pharmaceutics · 1998 · 19 citations

Lymphatic Uptake, Lipid Synthesis, Biochemistry +9